Article
A phylogenetic and Markov model approach for the reconstruction of mutational pathways of drug resistance.
Bioinformatics (Oxford, England) - 1 Oct 2009
Buendia Patricia, Cadwallader Brice, DeGruttola Victor
Abstract excerpt
MOTIVATION: Modern HIV-1, hepatitis B virus and hepatitis C virus antiviral therapies have been successful at keeping viruses suppressed for prolonged periods of time, but therapy failures attributable to the emergence of drug resistant mutations continue to be a distressing reminder that no therapy can fully eradicate these viruses from their host organisms. To better understand the emergence of drug resistance,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
